Abstract
There has been international debate on the infrequent occurrence of malignant hyperthermia in infants, where some reports state that this phenomenon does not exist in this age group; but the vast majority of studies counteract this argument. The proportion of documented cases in the infant population warrants a good review of cases and description of symptomatology observed with malignant hyperthermia in this cohort. It is paramount for clinicians of the pediatric population to recognize patients at risk of having a crisis, and to communicate this concern to the surgical/anesthetic team and also to be cognizant of the level of care necessary following a crisis.
Original language | English (US) |
---|---|
Pages (from-to) | 557-562 |
Number of pages | 6 |
Journal | Clinical Pediatrics |
Volume | 54 |
Issue number | 6 |
DOIs | |
State | Published - Jun 11 2015 |
Keywords
- anesthesia
- critical care
- dantrolene
- fever
- malignant hyperthermia
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health